• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ON-X LIFE TECHNOLOGIES, INC. ON-X ASCENDING AORTIC PROSTHESIS WITH THE VASCUTEK GELWEAVE VALSALVA GRAFT (ONXA; HEART VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ON-X LIFE TECHNOLOGIES, INC. ON-X ASCENDING AORTIC PROSTHESIS WITH THE VASCUTEK GELWEAVE VALSALVA GRAFT (ONXA; HEART VALVE, MECHANICAL Back to Search Results
Model Number ONXAAP-27/29
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Stroke/CVA (1770)
Event Date 03/02/2024
Event Type  Injury  
Manufacturer Narrative
This investigation is currently ongoing.Any additional information will be provided in the follow-up report.This report is being submitted as required by federal regulations and does not constitute an admission that the device caused or contributed to the reported event.Furthermore, this report reflects the event as alleged by the complainant and does not imply that the information reported to artivion is accurate or has been confirmed by artivion.
 
Event Description
According to the medwatch form received via email from the fda medical device reporting team on 03/25/2024, "status post repair utilizing a #28 gel weave graft, aortic valve replacement utilizing a 27/29 on-x mechanical valve and ligation of the patent ductus arteriosus in (b)(6) 2023, was on coumadin with inr goal 2.5-3.5 for 3 months following valve placement and then decreased to 1.5-2.5 per recommendations from previous studies, inr 2 on arrival.Had been at lower goal for 3 weeks and presented to emergency department with left sided weakness on (b)(6) 2024.Found to have middle cerebral artery, cerebral vascular accident, underwent mechanical thrombectomy (b)(6) 2024.Echo (b)(6) 2024 showed echogenic structure noted within the left atrium along with the intra-atrial septum, not mobile.Transesophageal echocardiography ordered.¿.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ON-X ASCENDING AORTIC PROSTHESIS WITH THE VASCUTEK GELWEAVE VALSALVA GRAFT (ONXA
Type of Device
HEART VALVE, MECHANICAL
Manufacturer (Section D)
ON-X LIFE TECHNOLOGIES, INC.
1300 east anderson lane
austin TX 78752
Manufacturer (Section G)
ON-X LIFE TECHNOLOGIES, INC.
1300 east anderson lane
austin TX 78752
Manufacturer Contact
rochelle maney
1655 roberts boulevard nw
kennesaw, GA 30144
7704193355
MDR Report Key19005898
MDR Text Key338981894
Report Number1649833-2024-00024
Device Sequence Number1
Product Code LWQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional
Reporter Occupation Nurse Practitioner
Type of Report Initial
Report Date 03/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/29/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberONXAAP-27/29
Was Device Available for Evaluation? No
Date Manufacturer Received03/25/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Hospitalization;
-
-